For NZ residents only
  • Prescribing Information
  • Patient Information
  • Visit NZ HCP site
  • NUCALA also treats
    • Severe Eosinophilic
      Asthma
    • Chronic Rhinosinusitis
      with Nasal Polyps
    • Eosinophilic Granulomatosis
      with Polyangiitis
  • Prescribing Information
    • Prescribing Information
    • Patient Information
    • Visit NZ HCP site
    • NUCALA also treats:
    • Severe Eosinophilic Asthma
    • Chronic Rhinosinusitis
      with Nasal Polyps
    • Eosinophilic Granulomatosis
      with Polyangiitis
logo
logo
search
Search

Cost share program

Search Results

No Results Found!

Home | Cost share program

For every 2 Nucala 100 mg Pre-filled Pens purchased privately by the patient through a participating pharmacy, eligible patients can receive their third pre-filled pen at no additional cost.

Home | Program description

For every 2 Nucala 100 mg Pre-filled Pens purchased privately by the patient through a participating pharmacy, eligible patients can receive their third pre-filled pen at no additional cost.

Home | Eligibility

Severe eosinophilic asthma in patients 12 years and over

Home | How it works

The relevant specialist prescribes Nucala 100 mg Pre-filled Pen to the appropriate privately funded patient and introduces/discusses the Nucala Cost Share Program.

Important Safety Information:

Do not use NUCALA if you are allergic (hypersensitive) to mepolizumab or any of the ingredients in NUCALA1.

Do not use to treat sudden acute asthma exacerbations1.

The most common side effects of NUCALA are headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and stuffy nose1.

Tell your doctor or get emergency help right away if you think you are having an allergic reaction to NUCALA2.

Any information provided on this website should be discussed with a healthcare professional and does not replace a healthcare professional’s advice.

References:
  1. GlaxoSmithKline New Zealand Nucala (mepolizumab) Data Sheet; December 2024. Available at https://www.medsafe.govt.nz/profs/Datasheet/n/nucalainj.pdf. Last Accessed February 2025.
  2. GlaxoSmithKline New Zealand. Nucala Consumer Medicine Information. GSK NZ; 2023. Available at https://www.medsafe.govt.nz/Consumers/CMI Last accessed February 2025
Nucala (mepolizumab 100 mg) is a Prescription Medicine, available as a 100 mg/mL pre-filled pen (auto-injector). Each pre-filled pen delivers 100 mg mepolizumab in 1 mL. Nucala is used as an add-on treatment for; severe eosinophilic asthma in patients 12 years and over, severe chronic rhinosinusitis with nasal polyps (CRSwNP) with an inadequate response to intranasal corticosteroids in adult patients 18 years and older, relapsing or refractory Eosinophilic Granulomatosis with Polyangiitis (EGPA) in adult patients aged 18 years and over, and in adult patients with inadequately controlled hypereosinophilic syndrome (HES) without an identifiable non-haematologic secondary cause. Nucala is given by injection under your skin (subcutaneous). Nucala is fully funded for severe eosinophilic asthma and EGPA only; Special Authority criteria apply. Use strictly as directed. Nucala has risks and benefits. Do not stop taking your other asthma medications including inhaled and /or oral steroid asthma medications. Tell your doctor if: you have a parasitic (helminth) infection; you are taking prescription and over-the-counter medicines, vitamins, and herbal supplements; you are pregnant or plan to become pregnant; you are breastfeeding or plan to breastfeed. Nucala does not treat acute asthma symptoms, such as sudden asthma attack. Tell your healthcare professional or get emergency help immediately if you have any of the following symptoms of an allergic reaction: swelling of your face, mouth, and tongue, breathing problems, fainting, dizziness, feeling light-headed (low blood pressure), rash or hives. Side effects: headache, injection site reactions (pain, redness, swelling, itching, or a burning feeling at the injection site), back pain, and fatigue. Serious side effects may include allergic (hypersensitivity) reactions, including anaphylaxis. Serious allergic reactions can happen after you get your injection of Nucala. Allergic reactions can sometimes happen hours or days after you get a dose of Nucala. Herpes zoster infections that can cause shingles have happened in people who received Nucala. If symptoms continue or you have side effects, see your doctor, pharmacist or health care professional. For more information, see Nucala Consumer Medicine Information at www.medsafe.govt.nz. Ask your doctor if Nucala is right for you. Normal doctor’s charges apply.
Patient Information | Terms of use | Privacy Policy | Contact Us
gsk-logo

Trademarks are owned by or licensed to the GSK group of companies. ©2025 GSK group of companies or its licensor. Marketed by GlaxoSmithKline NZ Limited, Auckland.

Adverse events involving GlaxoSmithKline products should be reported to GSK Medical Information on 0800 808 500.

TAPS NP22337 PM-NZ-MPL-WCNT-250001 Date of Approval 03 2025 Date of Expiry 03 2027.